[go: up one dir, main page]

MX2009006656A - Formulaciones homogeneas en pasta y gel. - Google Patents

Formulaciones homogeneas en pasta y gel.

Info

Publication number
MX2009006656A
MX2009006656A MX2009006656A MX2009006656A MX2009006656A MX 2009006656 A MX2009006656 A MX 2009006656A MX 2009006656 A MX2009006656 A MX 2009006656A MX 2009006656 A MX2009006656 A MX 2009006656A MX 2009006656 A MX2009006656 A MX 2009006656A
Authority
MX
Mexico
Prior art keywords
optionally
provides
gel formulations
homogeneous paste
veterinary
Prior art date
Application number
MX2009006656A
Other languages
English (en)
Inventor
Hassan Nached
Peter Hanson
Keith Freehauf
Original Assignee
Merial Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/713,881 external-priority patent/US20080027011A1/en
Application filed by Merial Ltd filed Critical Merial Ltd
Publication of MX2009006656A publication Critical patent/MX2009006656A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

La invención proporciona una formulación farmacéutica o veterinaria en pasta o gel que puede comprender una cantidad efectiva de un agente terapéutico; opcionalmente un absorbente o modificador de la viscosidad; opcionalmente un portador hidrófilo, un colorante, estabilizador, surfactante o conservante y opcionalmente un antioxidante, solvente, saborizante, sistema amortiguador o espesante y métodos para preparar estas formulaciones. Esta invención también proporciona, entre otras cosas, geles o pastas orales homogéneas de uso veterinario para el tratamiento, control y prevención de infestaciones endo- y exoparasitarias en animales homeotérmicos como aves, caballos y mascotas domésticas.
MX2009006656A 2007-03-05 2007-12-19 Formulaciones homogeneas en pasta y gel. MX2009006656A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/713,881 US20080027011A1 (en) 2005-12-20 2007-03-05 Homogeneous paste and gel formulations
PCT/US2007/088225 WO2008077130A2 (en) 2006-12-19 2007-12-19 Homogeneous paste and gel formulations

Publications (1)

Publication Number Publication Date
MX2009006656A true MX2009006656A (es) 2009-08-07

Family

ID=40984939

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009006656A MX2009006656A (es) 2007-03-05 2007-12-19 Formulaciones homogeneas en pasta y gel.

Country Status (4)

Country Link
EP (1) EP2101736A4 (es)
CA (1) CA2673193C (es)
MX (1) MX2009006656A (es)
WO (1) WO2008077130A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017310506B2 (en) 2016-08-11 2019-11-21 Dmk Pharmaceuticals Corporation Drug compositions
US11564910B2 (en) 2017-12-08 2023-01-31 Adamis Pharmaceuticals Corporation Drug compositions
US20190343875A1 (en) * 2018-01-18 2019-11-14 Zoetis Broomhill Ip Limited Internal teat sealants and their use in the prevention of bovine mastitis in the dry cow
US10857151B1 (en) * 2020-02-21 2020-12-08 Villya LLC Treatment of female genital schistosomiasis
US20220047506A1 (en) 2020-08-12 2022-02-17 Villya LLC Praziquantel Formulations
WO2024158694A1 (en) 2023-01-23 2024-08-02 Villya LLC Compositions and methods for improving the solubility of erectile dysfunction therapeutics

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6787342B2 (en) * 2000-02-16 2004-09-07 Merial Limited Paste formulations
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
AU2004308360B2 (en) * 2003-12-22 2012-02-16 Imrex, Inc. Methods and compositions for oral hygiene
US8097614B2 (en) * 2005-02-17 2012-01-17 Velcera Pharmaceuticals, Inc. Transmucosal administration of meloxicam compositions for treating and preventing disorders in non-human domesticated animals

Also Published As

Publication number Publication date
WO2008077130A3 (en) 2008-08-21
EP2101736A2 (en) 2009-09-23
EP2101736A4 (en) 2012-09-19
CA2673193C (en) 2014-08-05
WO2008077130A2 (en) 2008-06-26
CA2673193A1 (en) 2008-06-26

Similar Documents

Publication Publication Date Title
CY1116180T1 (el) Συνθεσεις ομογενους παστας
TNSN04258A1 (en) Anthelmintic oral homogeneous veterinary pastes
TW200621238A (en) Pharmaceutical formulation
BR0108449A (pt) Formulações de pasta aperfeiçoada
MX2009006656A (es) Formulaciones homogeneas en pasta y gel.
MX2017005721A (es) Composicion veterinaria masticable agradable al paladar.
IL271291B (en) History of n2,n4-diphenylpyrimidine-2,4-diamine, a method for their preparation, and a pharmaceutical preparation containing them as an active ingredient for the prevention or treatment of cancer
CR8480A (es) Formulaciones veterinarias que contienen producto no animal
WO2010059719A3 (en) Dimeric 1-arylpyrazole derivatives
MX356926B (es) Formulación de isoxazolina tópica localizada.
DK2219665T3 (da) Parathyroidhormonformuleringer og anvendelse deraf
WO2009129352A8 (en) Device and method for accessing and treating ducts of mammary glands
BR112015028692A8 (pt) agente preventivo ou terapêutico para mastite de animal ruminante
EA200900211A1 (ru) Замещенные производные имидазолона, их получение и применение
MX2010009743A (es) Uso de derivados de pirimidina para el tratamiento de las enfermedades dependientes de los receptores del factor de crecimiento epidermico (egfr) o de enfermedades que hayan adquirido resistencia a los agentes que se dirigen a los miembros de la fami
IL284930A (en) History of pyrrolopyrimidines and their use in the treatment of protein kinase-related diseases
MX358476B (es) Formulaciones de moxidectina inyectables de larga acción y formas de cristal de moxidectina novedosas.
EP1561457A3 (en) Cosmetic compositions with long lasting skin moisturizing properties
EP4384282A4 (en) COMPOSITIONS, FORMULATIONS AND METHODS OF HAIR TREATMENT
WO2018047013A8 (en) Formulations of 4-methyl-5-(pyrazin-2-yl)-3h-1, 2-dithiole-3-thione, and methods of making and using same
EP3352750A4 (en) Cyclohexene derivative, preparation method thereof, and pharmaceutical composition for preventing or treating metabolic disease comprising the same as active ingredient
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
WO2014144584A3 (en) Lactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated diseases and conditions
WO2009045575A3 (en) Unmarked recombinant intracellular pathogen immunogenic compositions expressing high levels of recombinant proteins
KR102481204B9 (ko) 카누카꿀을 유효성분으로 포함하는 화장료 조성물

Legal Events

Date Code Title Description
FA Abandonment or withdrawal